Skip to main content
. 2014 Jun 3;7(4):413–426. doi: 10.1007/s40271-014-0064-1

Table 6.

Willingness to pay estimates for chronic obstructive pulmonary disease attributes by gender (N = 515)

Attributes and levels Marginal WTP to avoid level by gender (95 % CI)
Male (N = 230) Female (N = 285)
Relieves symptoms (reference: complete relief)
 Little or no relief $69.71 (60.62–78.80) $59.10 (52.34–65.86)
 Some relief $27.30 (18.21–36.38) $27.58 (20.83–34.34)
Feel medicine start to work (reference: within 5 min)
 Within 20 min $10.36 (6.63–14.09) $9.72 (6.89–12.54)
 Within 30 min or more $11.45 (7.72–15.18) $14.12 (11.29–16.94)
Ease of use (reference: quick and easy)
 Requires some practice and care $8.00 (3.78–12.22) $2.58 (−0.48–5.64)
 More difficult and time-consuming $18.57 (14.35–22.79) $13.32 (10.25–16.38)
Rescue medicine use (reference: rarely, 1–2 times per week or less)
 3–5 times per week $23.29 (15.23–31.34) $17.86 (11.87–23.85)
 Every day $35.23 (27.18–43.29) $29.29 (23.30–35.27)
Side effects (reference: no side effects)
 Mild side effects $12.99 (8.97–17.01) $15.92 (12.95–18.90)
 Moderate to severe side effects $67.57 (63.55–71.59) $52.44 (49.47–55.42)

Reference was the most favorable level for each COPD medication attribute. 95 % CIs that did not include zero were considered to be statistically significant

CI confidence interval, COPD chronic obstructive pulmonary disease, WTP willingness to pay